Stephen DuBois
@Camber Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$3.149BTotal holdings33
Assets growth rate-12.86%Assets growth rate (2-Q avg)-12.15%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Camber Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 33 positions.
Assets under management
The assets under management (AUM) of Camber Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.149B in assets, with a quarterly growth rate of -12.86% and a 2-quarter average growth rate of -12.15%. The portfolio is managed by Stephen DuBois, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SPYSpdr S&p 500 Etf Tr
| 18.23% | $573.76M↓ Put 1M shares@ $573.76 avg price | Decreased -42.85% |
ZBHZimmer Biomet Holdings Inc
| 8.58% | $269.875M 2.5M shares@ $107.95 avg price | Increased 29.88% |
MDTMedtronic Plc
| 7.87% | $247.583M 2.75M shares@ $90.04 avg price | Increased 22.23% |
BAXBaxter Intl Inc
| 7.84% | $246.805M 6.5M shares@ $37.97 avg price | Increased 18.19% |
VTRSViatris Inc
| 5.54% | $174.15M 15M shares@ $11.61 avg price | |
GMEDGlobus Med Inc
| 4.89% | $153.811M 2.15M shares@ $71.54 avg price | Decreased -14% |
PTCTPtc Therapeutics Inc
| 4.13% | $129.85M 3.5M shares@ $37.1 avg price | |
JAZZJazz Pharmaceuticals Plc
| 4.07% | $128.122M 1.15M shares@ $111.42 avg price | |
GSKGsk Plc
| 3.9% | $122.64M 3M shares@ $40.88 avg price | Increased 12.15% |
MYGNMyriad Genetics Inc
| 3.44% | $108.191M 3.95M shares@ $27.4 avg price | Decreased -28.18% |